FDAnews
www.fdanews.com/articles/82160-drug-development-meetings

Drug Development Meetings

November 3, 2005

Join FDAnews Thursday, Nov. 10, for a 90-minute audioconference on "DDMAC Warning Letters: Avoid Regulatory Action." In 90 minutes, expert Keith Korenchuk walks you through five recent ads that triggered DDMAC warning letters. You'll learn exactly where the advertisers went wrong -- and how to avoid similar violations as you develop your own promotions. On Nov. 16, join FDAnews for "Best Practices in CAPA: Crucial Steps to Take BEFORE Your Next Inspection." During this 90-minute audioconference, compliance expert Barbara Immel will take you through three powerful case studies drawn from actual FDA warning letters and publicly available Form 483s related to CAPA. She'll explain the possible root causes and provide strategies for managing CAPA.

Nov. 6-8: Key Challenges and Solutions in the Development of Therapeutic Products

San Diego, Calif.

(215) 957-0300

Drug Information Association

apawlowski@dbcommunications.net

www.diahome.org/Contents/Events/05022.pdf

Nov. 10-11: Parenteral Drug Development

Malvern, Pa.

(610) 688-1708

The Center for Professional Innovation & Education

info@cfpie.com

www.cfpie.com

Nov. 14-15: CHI'S Second Annual Fluorescent Proteins in Drug Development

La Jolla, Calif.

(617) 630-1300

Cambridge Healthtech Institute

chi@healthtech.com

www.healthtech.com

Nov. 14-17: Basic Training Course in Drug Development

Washington, D.C.

(703) 276-0178

Peri

maria.simonetti@peri.org

www.peri.org

Nov. 16-17: Issues in Design and Analysis of Trials in Community-Acquired Pneumonia

Tucson, Ariz.

(215) 442-6100

DIA / CPATH

jessica.kusma@diahome.org

www.diahome.org

Nov. 17-18: Peptides and Therapeutic Proteins: New Opportunities for Macromolecule Development, Delivery and Commercialization

Philadelphia , Pa.

(212) 967-0095

Strategic Research Institute

edrilon@srinstitute.com

www.srinstitute.com/cs352

Nov. 17-18: Test Method Validation in Pharmaceutical Development and Production

Las Vegas, Nev.

(608) 262-2101

University of Wisconsin

waxman@engr.wisc.edu

http://epdweb.engr.wisc.edu/courses/Nov. 29-Dec. 1: Clinical Drug Development from Strategy to Implementation - Oncology as a case study

www.diahome.org

(215) 442-6100

DIA

ellen.diegel@diahome.org

www.diahome.org

Nov. 29-30: The EU Clinical Trial Directive

Malvern, Pa.

(610) 688-1708

The Center for Professional Innovation & Education

info@cfpie.com

www.cfpie.com

Nov. 29-Dec. 1: Clinical Drug Development from Strategy to Implementation - Oncology as a case study

www.diahome.org

(215) 442-6100

DIA

ellen.diegel@diahome.org

www.diahome.org

Nov. 30-Dec. 2: Non-clinical Drug Safety Evaluation & Drug Development

Amsterdam, The Netherlands

(732) 238-1600

The Center for Professional Advancement

info@cfpa.com

www.cfpa.com

Dec. 5-7: Cardiovascular Drug Development

Boston, Mass.

(703) 276-0178

Peri

maria.simonetti@peri.org

www.peri.org